News & Analysis as of

Capital Markets › Startups › Investors

Orrick, Herrington & Sutcliffe LLP

From Federal to State: Building the New Life Sciences Capital Stack | Life Sciences Snapshot – Q3 2025

Orrick, Herrington & Sutcliffe LLP on

This year, U.S. VC funding into the life sciences sector has cooled: Q1 softness was followed by a decade low in VC transactions in Q2. Despite the moderation in dealmaking volume, investors continued to deploy sizable...more

Fenwick & West LLP

Q1 2025 Venture Snapshot: Selectivity Over Scale

Fenwick & West LLP on

After a cautiously optimistic close to 2024, Q1 2025 brought a measured pullback in venture activity. Rather than a dramatic downturn, the market saw a strategic recalibration....more

Farrell Fritz, P.C.

Pitch Perfect: Demo Days, General Solicitation and the HALOS Act of 2025

Farrell Fritz, P.C. on

Your company is invited by a local meetup group to present at demo day with other startups, and you accept.  The group announces the demo day lineup of startups in an e-blast, on its website, on its Facebook page and through...more

Lowenstein Sandler LLP

Eunice Ajim on Wining & Dining Africa Before Investing

Lowenstein Sandler LLP on

In this episode of Venture Voices, host Rossie E. Turman III chats with Eunice Ajim, a Cameroonian-American tech entrepreneur and founding partner of Ajim Capital, about navigating African markets and startups. They cover the...more

Oberheiden P.C.

Regulation A+: The Ultimate Guide from Eligibility to Compliance

Oberheiden P.C. on

Regulation A+ has emerged as a powerful tool for companies seeking to raise capital from both accredited and non-accredited investors. This Regulation A+ Offerings Guide provides a comprehensive overview of Regulation A+,...more

Orrick, Herrington & Sutcliffe LLP

Deal Flow 5.0: 5 Things We Learned About European Tech Deal Terms in 2024

Orrick, Herrington & Sutcliffe LLP on

In 2024, despite political and regulatory challenges, Europe's talent pool reached new heights, even amid funding shortages. Venture capital investment in European startups reached over $52B last year, aligning with the...more

Jones Day

JONES DAY TALKS®: Five Pillars of Series A Shareholder Rights: A Discussion for VC Investors

Jones Day on

The challenges and mechanics of growing a new venture are complex, and when the competing interests of different investor classes are considered, trouble and conflict are possible. As part of a continuing series of podcasts...more

Foley & Lardner LLP

The Outlook for M&A Activity in Q4 2024

Foley & Lardner LLP on

In a highly anticipated move, the Federal Reserve announced an interest rate cut on September 18, reducing rates by 50 basis points to a range of 4.75-5%. This is the first rate cut in four years after interest rates hit a...more

Wilson Sonsini Goodrich & Rosati

[Event] Biotech Summit 2024 - October 9th - 10th, Boston, MA

Wilson Sonsini Goodrich & Rosati on

Wilson Sonsini’s inaugural Biotech Summit will address topics of critical importance to Biotech and Biopharmaceutical companies, including early and late-stage venture financing, partnering strategies, current and future AI...more

Perkins Coie

New Space Investments and Acquisitions Take Off

Perkins Coie on

This article is the first of a series by the Perkins Coie New Space industry group on developments in the "new space" industry. Responsible for lowering the cost to access space, the "new space" industry has been developing...more

10 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide